Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin R Dosch

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic CancerSamara P Singh, Austin R Dosch, Siddharth Mehra, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 13, 2022
Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signalingSiddharth Mehra, Supriya Srinivasan, Samara Singh, et al.
Molecular Cancer Therapeutics|November 9, 2018
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.
Gastroenterology|August 10, 2022
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic CancerJashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Activation of CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in animal models of alcoholic pancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 14, 2025
CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic PancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Annals of Surgical Oncology|February 21, 2025
Nonoperative Management of Rectal Cancer: Is "Near-Complete" Response Safe to Surveil?Catherine N Zivanov, Nathan S Kau, Harika Nalluri-Butz, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancerSiddharth Mehra, Supriya Srinivasan, Sudhakar Jinka, et al.
Oncogene|June 14, 2022
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerJashodeep Datta, Anna Bianchi, Iago De Castro Silva, et al.
Cancer Discovery|March 22, 2023
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic CancerAnna Bianchi, Iago De Castro Silva, Nilesh U Deshpande, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic CancerSamara P Singh, Austin R Dosch, Siddharth Mehra, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 13, 2022
Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signalingSiddharth Mehra, Supriya Srinivasan, Samara Singh, et al.
Molecular Cancer Therapeutics|November 9, 2018
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.
Gastroenterology|August 10, 2022
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic CancerJashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Activation of CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in animal models of alcoholic pancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 14, 2025
CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic PancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Annals of Surgical Oncology|February 21, 2025
Nonoperative Management of Rectal Cancer: Is "Near-Complete" Response Safe to Surveil?Catherine N Zivanov, Nathan S Kau, Harika Nalluri-Butz, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancerSiddharth Mehra, Supriya Srinivasan, Sudhakar Jinka, et al.
Oncogene|June 14, 2022
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerJashodeep Datta, Anna Bianchi, Iago De Castro Silva, et al.
Cancer Discovery|March 22, 2023
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic CancerAnna Bianchi, Iago De Castro Silva, Nilesh U Deshpande, et al.
Pageof 3